597 related articles for article (PubMed ID: 15121646)
21. D2 receptor occupancy following lurasidone treatment in patients with schizophrenia or schizoaffective disorder.
Potkin SG; Keator DB; Kesler-West ML; Nguyen DD; van Erp TG; Mukherjee J; Shah N; Preda A
CNS Spectr; 2014 Apr; 19(2):176-81. PubMed ID: 24073841
[TBL] [Abstract][Full Text] [Related]
22. Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D2 receptors: a PET study in schizophrenia.
Mizrahi R; Rusjan P; Agid O; Graff A; Mamo DC; Zipursky RB; Kapur S
Am J Psychiatry; 2007 Apr; 164(4):630-7. PubMed ID: 17403977
[TBL] [Abstract][Full Text] [Related]
23. Dopamine D2/3 receptor occupancy by quetiapine in striatal and extrastriatal areas.
Vernaleken I; Janouschek H; Raptis M; Hellmann S; Veselinovic T; Bröcheler A; Boy C; Cumming P; Hiemke C; Rösch F; Schäfer WM; Gründer G
Int J Neuropsychopharmacol; 2010 Aug; 13(7):951-60. PubMed ID: 20392299
[TBL] [Abstract][Full Text] [Related]
24. Quetiapine: an effective antipsychotic in first-episode schizophrenia despite only transiently high dopamine-2 receptor blockade.
Tauscher-Wisniewski S; Kapur S; Tauscher J; Jones C; Daskalakis ZJ; Papatheodorou G; Epstein I; Christensen BK; Zipursky RB
J Clin Psychiatry; 2002 Nov; 63(11):992-7. PubMed ID: 12444812
[TBL] [Abstract][Full Text] [Related]
25. Estimated dopamine D₂ receptor occupancy and remission in schizophrenia: analysis of the CATIE data.
Moriguchi S; Bies RR; Remington G; Suzuki T; Mamo DC; Watanabe K; Mimura M; Pollock BG; Uchida H
J Clin Psychopharmacol; 2013 Oct; 33(5):682-5. PubMed ID: 23899638
[TBL] [Abstract][Full Text] [Related]
26. Estimating dopamine D₂ receptor occupancy for doses of 8 antipsychotics: a meta-analysis.
Lako IM; van den Heuvel ER; Knegtering H; Bruggeman R; Taxis K
J Clin Psychopharmacol; 2013 Oct; 33(5):675-81. PubMed ID: 23948784
[TBL] [Abstract][Full Text] [Related]
27. Dopamine D2 receptor occupancy by perospirone: a positron emission tomography study in patients with schizophrenia and healthy subjects.
Arakawa R; Ito H; Takano A; Okumura M; Takahashi H; Takano H; Okubo Y; Suhara T
Psychopharmacology (Berl); 2010 May; 209(4):285-90. PubMed ID: 20349050
[TBL] [Abstract][Full Text] [Related]
28. Ziprasidone for psychotic disorders: a meta-analysis and systematic review of the relationship between pharmacokinetics, pharmacodynamics, and clinical profile.
Stip E; Zhornitsky S; Moteshafi H; Létourneau G; Stikarovska I; Potvin S; Tourjman V
Clin Ther; 2011 Dec; 33(12):1853-67. PubMed ID: 22133697
[TBL] [Abstract][Full Text] [Related]
29. Striatal dopaminergic D2 receptor occupancy and clinical efficacy in psychosis exacerbation: a 123I-IBZM study with ziprasidone and haloperidol.
Corripio I; Catafau AM; Perez V; Puigdemont D; Mena E; Aguilar Y; Carrió I; Alvarez E
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):91-6. PubMed ID: 15610950
[TBL] [Abstract][Full Text] [Related]
30. Atypical antipsychotics: mechanism of action.
Seeman P
Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
[TBL] [Abstract][Full Text] [Related]
31. The psychopharmacology of ziprasidone: receptor-binding properties and real-world psychiatric practice.
Stahl SM; Shayegan DK
J Clin Psychiatry; 2003; 64 Suppl 19():6-12. PubMed ID: 14728084
[TBL] [Abstract][Full Text] [Related]
32. Is regionally selective D2/D3 dopamine occupancy sufficient for atypical antipsychotic effect? an in vivo quantitative [123I]epidepride SPET study of amisulpride-treated patients.
Bressan RA; Erlandsson K; Jones HM; Mulligan R; Flanagan RJ; Ell PJ; Pilowsky LS
Am J Psychiatry; 2003 Aug; 160(8):1413-20. PubMed ID: 12900302
[TBL] [Abstract][Full Text] [Related]
33. The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia.
Gründer G; Landvogt C; Vernaleken I; Buchholz HG; Ondracek J; Siessmeier T; Härtter S; Schreckenberger M; Stoeter P; Hiemke C; Rösch F; Wong DF; Bartenstein P
Neuropsychopharmacology; 2006 May; 31(5):1027-35. PubMed ID: 16237387
[TBL] [Abstract][Full Text] [Related]
34. Subjective experience and D2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study.
de Haan L; van Bruggen M; Lavalaye J; Booij J; Dingemans PM; Linszen D
Am J Psychiatry; 2003 Feb; 160(2):303-9. PubMed ID: 12562577
[TBL] [Abstract][Full Text] [Related]
35. Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response--a double-blind PET study in schizophrenia.
Agid O; Mamo D; Ginovart N; Vitcu I; Wilson AA; Zipursky RB; Kapur S
Neuropsychopharmacology; 2007 Jun; 32(6):1209-15. PubMed ID: 17077809
[TBL] [Abstract][Full Text] [Related]
36. Monthly administration of long-acting injectable risperidone and striatal dopamine D2 receptor occupancy for the management of schizophrenia.
Uchida H; Mamo DC; Kapur S; Labelle A; Shammi C; Mannaert EJ; Mann SW; Remington G
J Clin Psychiatry; 2008 Aug; 69(8):1281-6. PubMed ID: 18642974
[TBL] [Abstract][Full Text] [Related]
37. A PET study of 5-HT2 and D2 dopamine receptor occupancy induced by olanzapine in healthy subjects.
Nyberg S; Farde L; Halldin C
Neuropsychopharmacology; 1997 Jan; 16(1):1-7. PubMed ID: 8981383
[TBL] [Abstract][Full Text] [Related]
38. Occupancy of striatal and extrastriatal dopamine D2/D3 receptors by olanzapine and haloperidol.
Kessler RM; Ansari MS; Riccardi P; Li R; Jayathilake K; Dawant B; Meltzer HY
Neuropsychopharmacology; 2005 Dec; 30(12):2283-9. PubMed ID: 16123775
[TBL] [Abstract][Full Text] [Related]
39. Positron emission tomography studies on D2 and 5-HT2 receptor binding in risperidone-treated schizophrenic patients.
Farde L; Nyberg S; Oxenstierna G; Nakashima Y; Halldin C; Ericsson B
J Clin Psychopharmacol; 1995 Feb; 15(1 Suppl 1):19S-23S. PubMed ID: 7537284
[TBL] [Abstract][Full Text] [Related]
40. Significant dissociation of brain and plasma kinetics with antipsychotics.
Tauscher J; Jones C; Remington G; Zipursky RB; Kapur S
Mol Psychiatry; 2002; 7(3):317-21. PubMed ID: 11920159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
